Welcome to our dedicated page for Conduent news (Ticker: CNDT), a resource for investors and traders seeking the latest updates and insights on Conduent stock.
Conduent Incorporated reports developments for a global technology-driven business solutions and services company serving commercial, government and transportation clients. News commonly covers operating results, new business activity, cost and efficiency programs, and digital process services built around cloud computing, artificial intelligence, machine learning, automation and analytics.
Company updates also address GenAI-enabled finance and procurement tools such as FastCap, healthcare payer operations supported by Health Solutions Plus, HR service modernization, electronic benefits transfer security, tolling services and public-sector payment programs. Governance announcements, including board and senior leadership changes, are recurring corporate news themes for CNDT.
Conduent (NASDAQ: CNDT) reported Q4 2021 revenue of $1,048M, slightly down 0.7% YoY, and FY 2021 revenue of $4,140M, flat compared to the previous year. Adjusted EBITDA margin decreased to 10.9% in Q4 from 12.6% in Q4 2020, with full year margin at 11.8%. New business Annual Recurring Revenue (ARR) reached $111M in Q4, totaling $408M for the year. The Net ARR Activity metric was strong at $128M, reflecting growth for five consecutive quarters. Company outlook for FY 2022 anticipates revenue between $3,825M and $3,975M.
Conduent Transportation has secured three 8-year contract renewals from New York tolling authorities worth approximately $488 million to enhance E-ZPass account management and Tolls by Mail programs. These contracts reflect trust in Conduent's ability to deliver modern transportation solutions, including transaction processing and financial management systems. Additionally, Conduent plans to support New York City's first congestion pricing program pending federal approval. The company operates six of the ten largest toll systems in the U.S. and continues to enhance customer experience through technology.
Conduent (Nasdaq: CNDT) has finalized the sale of its Midas Suite of Solutions to symplr for $340 million, resulting in net proceeds of approximately $270 million for the company. These funds will be utilized for debt repayment and further investments in its business. This transaction aligns with Conduent’s strategy to maximize synergies within its portfolio to boost shareholder and client value. The company remains committed to providing healthcare solutions that enhance member experiences, automate claims, and streamline operations, serving 75% of U.S. insured patients.
Conduent (NASDAQ: CNDT) has secured a five-year agreement to provide health plan management services for the Uniformed Services Family Health Plan (USFHP) at Saint Vincents Catholic Medical Center. This selection follows a competitive bid process and emphasizes scalable solutions in claims processing, member engagement, and fulfillment. USFHP serves military families in the Northeastern U.S. and chose Conduent for its proven expertise and ability to adapt to the evolving healthcare landscape. This partnership aims to enhance operational efficiency and member health outcomes.
Conduent Incorporated (Nasdaq: CNDT) will announce its fourth quarter and full year 2021 financial results on February 16, 2022, post-market close. A conference call will follow at 5:00 p.m. ET to discuss the results. Interested parties can access the call via a live audio webcast or dial-in options. Conduent provides critical services to businesses and governments, improving workflow and efficiency, with significant impacts on operations for clients, including Fortune 100 companies and various government entities.
Conduent (CNDT) has been named a 'Rising Star' in the 2021 ISG Provider Lens™ Healthcare Digital Services Report by ISG, a technology research firm. It received this recognition for its strong portfolio in Payer Digital Transformation Services and Payer Business Process as a Service (BPaaS). The report highlighted Conduent's end-to-end capabilities that enhance member engagement and improve healthcare outcomes. Additionally, the company was recognized as a 'Product Challenger' in Healthcare Interoperability Services & Solutions, showcasing its investment in market presence.
Summary not available.
Summary not available.
Conduent (Nasdaq: CNDT) has announced a definitive agreement to sell its Midas Suite of Solutions to symplr for $340 million in cash. The Midas suite, generating $72 million in 2020 revenue, supports approximately 2,200 healthcare facilities. This divestiture aligns with Conduent's strategy to streamline operations and enhance shareholder value, with a focus on a smooth transition for clients and team members. The transaction is set to close in the first quarter of 2022, pending regulatory approvals.
Summary not available.